GLP-1 medications can lead to some lean mass loss during weight loss, but that does not mean they directly “waste” muscle in everyone. The main drivers are rapid weight loss, low protein intake, lower food intake, nausea, and not strength training. Most patients can lower risk with clinician-guided treatment, resistance exercise, and enough protein.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Do GLP-1 medications cause muscle loss?
GLP-1 receptor agonists and other incretin-based therapies can be associated with lean mass loss during weight loss, but current reviews do not support telling every patient that they cause dangerous muscle wasting by themselves 1 2. The more useful question is: are you losing weight in a way that protects strength, mobility, and nutrition?
What “muscle loss” means versus lean mass loss
In studies, “lean mass” or “fat-free mass” is not the same as pure skeletal muscle. It can include water, organs, connective tissue, and glycogen, which is stored carbohydrate in muscle and liver 3. So a drop in lean mass on a scan does not always mean the person lost the same amount of working muscle.
Why weight loss often includes some lean mass loss
When body weight falls, some fat-free mass often falls too. This can happen with diet, exercise, surgery, and medication-assisted weight loss 2. The risk tends to matter more when weight loss is fast, protein intake is low, training stops, or the person starts with low muscle reserve.
Why the goal is muscle function, strength, and metabolic health
Scale weight alone can miss the point. Muscle strength, walking speed, ability to climb stairs, waist size, blood pressure, glucose markers, and how you feel day to day can give a fuller picture than pounds lost alone 1. If you are losing strength, feeling weak, or eating very little, that deserves medical review.
Why can muscle loss happen while taking a GLP-1?
Appetite suppression is one reason GLP-1 treatment can change muscle risk within the first weeks or months of treatment. If you eat much less food, you may also eat less protein and have less energy for training.
- Reduced appetite can lower total calories and protein. Protein helps provide amino acids for muscle protein synthesis, the process of repairing and building muscle after training 4.
- Fast weight loss can include fat-free mass loss. Reviews of GLP-1-related weight loss describe lean mass changes as part of overall body composition change, not always as direct muscle injury 1 3.
- Nausea or food aversions can make protein harder to eat. Nausea, vomiting, constipation, and diarrhea are recognized GLP-1 side effects, and low intake can become a safety issue if it persists 5.
- Less activity during weight loss can reduce the muscle-building signal. Resistance training sends a signal to keep and build muscle; without it, the body has less reason to preserve muscle during an energy deficit 4.
If side effects are limiting food, fluids, or exercise, the answer is not to force through it. It is to tell your clinician. For a deeper guide to what is common versus concerning, see our article on side effects of weight loss.
How worried should you be about GLP-1 muscle loss?
Some lean mass loss is common during weight loss, but panic is not helpful. The level of concern depends on your age, baseline strength, medical history, rate of weight loss, food intake, and whether your physical function is changing.
People with obesity, overweight, type 2 diabetes, prediabetes, or insulin resistance can benefit from weight management, but they can also have different responses to exercise and protein. A randomized clinical trial analysis found that obesity and metabolic disease can blunt the anabolic response to protein supplementation and resistance exercise, which means the plan may need to be consistent and individualized 4.
Older adults, people with sarcopenia or sarcopenic obesity, people with chronic kidney disease, and people with frailty should be more careful. For example, dulaglutide (Trulicity, a GLP-1 receptor agonist) has been studied in people with type 2 diabetes and moderate-to-severe chronic kidney disease, showing why comorbidities matter when clinicians weigh treatment goals and monitoring 6.
| Your situation | What it may mean | Sensible next step |
|---|---|---|
| Weight is falling, strength is stable, protein intake is steady | Often a lower-risk pattern | Keep tracking strength, meals, side effects, and clinician follow-up |
| Weight is falling fast and appetite is very low | Higher risk of low protein, dehydration, and lean mass loss | Ask your clinician about side effects, intake, and whether the plan needs adjustment |
| You are older, frail, or starting with low muscle | Less reserve if lean mass falls | Consider closer monitoring, resistance training support, and nutrition guidance |
| You feel weak, dizzy, or cannot keep food or fluids down | Possible under-eating, dehydration, or medication intolerance | Get medical advice promptly |
| You want to gain muscle while losing weight | Possible, but often slower during an energy deficit | Use progressive strength training and enough protein; consider a coach, dietitian, or physical therapist |
How can you avoid losing muscle on a GLP-1?
Resistance training is the foundation. It gives your body a reason to keep muscle while weight is going down, and it works best when paired with enough protein and enough total energy to train safely.
- Lift, push, pull, squat, hinge, and carry in a way that fits your ability. Beginner plans can use machines, dumbbells, bands, or body weight. Our weight loss workout plan gives a simple starting structure.
- Use progressive overload. That means slowly increasing reps, sets, range of motion, or resistance when your body is ready.
- Prioritize protein at meals and snacks. Protein needs vary by body size, kidney health, age, and training status. For practical food ideas, see our guide to protein for muscle recovery.
- Avoid crash dieting on top of appetite suppression. A very low intake can worsen fatigue, nausea, constipation, and training drop-off.
- Track strength and function, not only weight. Note whether you can climb stairs, carry groceries, stand from a chair, and complete your workouts.
Exercise can help health even when it does not produce all the scale change a person expects. A human randomized trial of exercise for weight loss showed that energy compensation can affect weight results, which is why training, nutrition, and function should be judged together instead of by scale weight alone 7.
3-min quiz
Considering GLP-1 treatment with muscle protection in mind?
At Chia, patients can start with an online eligibility review for compounded semaglutide injection or compounded tirzepatide tablets or injection, when clinically appropriate. A licensed provider reviews your health history, side effects, goals, and risk factors; a prescription is not guaranteed. Compounded drugs are not FDA-approved and are prepared by US state-licensed 503A pharmacies.
How can you gain or regain muscle while on a GLP-1?
Muscle gain can happen during GLP-1 treatment, but it may be slower during active weight loss. Building muscle usually needs progressive strength training, enough protein, enough total energy, sleep, and recovery.
Start with a plan you can repeat. Two or more weekly strength sessions may be more useful than occasional hard workouts that leave you too sore to continue. If you have pain, balance problems, frailty, or a history of injury, physical therapy may be a safer starting point.
Nutrition matters too. If you are not sure how much protein fits your body size and health history, our protein calculator for weight loss guide can help you prepare better questions for your clinician or dietitian. People with kidney disease, eating disorders, pregnancy, frailty, or chronic illness should get individualized guidance before changing protein intake or exercise.
Experimental muscle-preservation drugs are being studied, but they are not standard add-ons for GLP-1 patients. For example, bimagrumab research has studied myostatin-activin pathway inhibition in specific populations and safety contexts, which is not the same as routine muscle protection for people taking GLP-1 medications 8.
What does the evidence say about exercise with GLP-1 treatment?
Human randomized evidence supports combining exercise with GLP-1-based treatment when the goal is better fitness and weight maintenance after weight loss. A 2026 secondary analysis studied physical fitness with exercise and GLP-1 receptor agonist treatment alone or combined after diet-induced weight loss in adults with obesity 9.
This matters because body composition, muscle quality, and physical function are not identical. A scan may show lean mass change, while a person’s fitness, walking capacity, or strength may tell a different story 1. The best monitoring plan looks at more than one measure.
Exercise intensity also needs to fit the person. In older adults with obesity and prediabetes, short-term exercise training intensity has been studied for beta-cell function, showing that exercise can affect metabolic health, but safety and starting point still matter 10.
What should patients ask before starting or continuing GLP-1 treatment?
Before starting or continuing semaglutide, tirzepatide, or another GLP-1 medication, ask how the plan will protect nutrition, strength, and safety. This is especially important if you already eat very little, have nausea, or have a history of disordered eating.
- Am I a good candidate for GLP-1 medication based on my medical history, medications, weight-related risk factors, and goals?
- What side effects could affect food intake, hydration, bowel habits, or training?
- How should I monitor weight, waist size, strength, protein intake, and energy?
- When should I report weakness, dizziness, vomiting, constipation, or signs of under-eating?
- If I hit a plateau, should we adjust nutrition, training, sleep, adherence, or medication strategy? Our guide to the GLP-1 plateau explains common reasons progress can stall.
The FDA warns that unapproved GLP-1 drugs used for weight loss should involve a prescription and an appropriate state-licensed pharmacy, and it lists red flags such as sellers that do not require medical screening or a prescription 5. The safety line we emphasize at Chia is licensed care: a real medical review, appropriate prescribing, pharmacy standards, and follow-up.
GLP-1 treatment at Chia: protecting weight loss quality with clinician-guided care
At Chia, GLP-1 care starts with a 100% online health questionnaire and review by a licensed US provider. We prescribe only when clinically appropriate, and a prescription is never guaranteed.
Chia offers compounded semaglutide injection, with plans currently starting at $249/mo, and compounded tirzepatide tablets or injection, with tablets currently starting at $249/mo and injection currently starting at $299/mo. Microdosing plans are available for semaglutide and tirzepatide when clinically appropriate and provider-guided.
For eligible patients whose goals include strength and body-composition support, Chia’s Weight + Muscle protocol pairs sermorelin injection with a choice of GLP-1 and currently starts at $329/mo. Chia’s Weight + Energy protocol pairs NAD+ injection with a choice of GLP-1 and currently starts at $309/mo. Sermorelin, NAD+, and other longevity treatments should not be viewed as proven to prevent GLP-1-related muscle loss; the core evidence-based protections remain training, nutrition, monitoring, and clinician oversight.
| Chia option | Forms listed in Chia catalog | Where it may fit | Important limits |
|---|---|---|---|
| Compounded semaglutide | Injection | Patients seeking clinician-guided GLP-1 treatment when appropriate | Compounded medication is not FDA-approved; prescription requires evaluation |
| Compounded tirzepatide | Tablets or injection | Patients who want a provider-guided incretin-based option with form choice | Eligibility, tolerability, and medical history guide the decision |
| Weight + Muscle | Sermorelin injection + choice of GLP-1 | Eligible patients interested in a combined protocol that includes a GLP-1 and sermorelin | Not proven to prevent GLP-1-related muscle loss |
| Weight + Energy | NAD+ injection + choice of GLP-1 | Eligible patients interested in a combined protocol that includes a GLP-1 and NAD+ | Not a substitute for food intake, hydration, sleep, or resistance training |
Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Patients can message their care team through the portal between visits, which matters if appetite, nausea, fatigue, weakness, or training capacity changes.
How do semaglutide and tirzepatide compare for muscle concerns?
Semaglutide and tirzepatide are both incretin-based medications used in weight management for appropriate patients. Semaglutide is the active ingredient in Wegovy and Ozempic; tirzepatide is the active ingredient in Zepbound and Mounjaro. Compounded semaglutide via a 503A pharmacy and compounded tirzepatide via a 503A pharmacy are separate compounded prescriptions, not generic versions of those brands.
| Topic | Semaglutide | Tirzepatide | Muscle-related takeaway |
|---|---|---|---|
| Drug class | GLP-1 receptor agonist | Dual incretin-based therapy acting on GIP and GLP-1 pathways | Both can reduce appetite, so nutrition monitoring matters |
| Brand examples | Wegovy, Ozempic | Zepbound, Mounjaro | Brand trial results should not be used as claims for compounded formulations |
| Chia forms | Compounded injection | Compounded tablets or injection | Form choice can affect convenience, but muscle protection still depends on training, intake, and follow-up |
| Microdosing at Chia | Available when clinically appropriate | Available when clinically appropriate | Do not microdose or change dose without clinician guidance |
| Muscle concern | Lean mass can fall during weight loss | Lean mass can fall during weight loss | More total weight loss can mean more need to protect lean mass |
The best option depends on eligibility, medical history, contraindications, current medications, side effects, goals, and clinician judgment. If someone is losing strength, struggling to eat, or having persistent nausea, the next step is a medical review rather than trying to solve it alone.
What changes over time on a GLP-1?
Over time, appetite, side effects, weight change, and training capacity can shift. The first weeks often focus on tolerability and hydration; later months often focus more on protein consistency, resistance training, plateaus, and long-term habits.
- First weeks: nausea, fullness, constipation, or food aversions can affect intake. Tell your clinician if you cannot meet basic food or fluid needs.
- First months: weight may fall more quickly for some people. This is when strength training and protein routines become especially important.
- After longer use: the focus often shifts to sustainability, plateaus, strength, labs, and whether the treatment plan still fits your goals.
- Any time: weakness, dizziness, repeated vomiting, dehydration, severe abdominal pain, or signs of under-eating need prompt medical advice.
When should you get help now?
Get medical help promptly if you have repeated vomiting, signs of dehydration, fainting, severe weakness, severe abdominal pain, confusion, or you cannot keep food or fluids down. These symptoms can be more important than any number on the scale.
Also check in if your strength drops, you stop normal daily activities, you are skipping most meals, or exercise suddenly feels unsafe. A clinician may review side effects, hydration, nutrition, labs, other medications, and whether the current treatment plan still fits.
3-min quiz
Start with a clinician-reviewed plan
If you are exploring GLP-1 care and want a plan that considers side effects, nutrition, strength, and follow-up, Chia’s online visit can help determine whether treatment is appropriate. Prescriptions are not guaranteed and depend on a licensed provider’s evaluation. Compounded medications are not FDA-approved.
Often, yes. Muscle can be rebuilt with progressive resistance training, enough protein, enough total energy, and recovery. The right pace depends on age, baseline strength, medical conditions, and whether you are still actively losing weight.
Use a repeatable strength plan, progress slowly, eat enough protein, avoid very low intake, and sleep enough. Muscle gain may be slower while weight is falling because your body has less extra energy available.
The main steps are resistance training, protein at meals and snacks, avoiding crash dieting, managing nausea early, and tracking strength and function. Ask your clinician for help if you feel weak, dizzy, or unable to eat enough.
Semaglutide can be associated with lean mass loss during weight loss, but lean mass is not the same as pure muscle. The risk depends on weight-loss speed, intake, training, age, and baseline muscle. Compounded semaglutide is not FDA-approved and does not have FDA-reviewed outcomes data.
Tirzepatide can be associated with lean mass loss as body weight falls. More total weight loss can make muscle-protection habits more important. The best plan depends on medical history, side effects, nutrition, activity, and clinician judgment.
Do not stop or change a prescription medication on your own. Contact your clinician if strength is dropping, you feel weak, or you cannot eat or drink enough. Your clinician can review side effects, nutrition, labs, and the treatment plan.
Some lean mass loss is common during weight loss, and lean mass includes more than muscle. What matters most is whether you are keeping strength, function, nutrition, and metabolic health. Concern is reasonable; panic is not needed.
Protein needs vary by body size, kidney health, age, goals, and activity. Many people benefit from spreading protein across meals, but anyone with kidney disease, pregnancy, frailty, an eating disorder history, or chronic illness should ask a clinician for individualized advice.
References
- 1.Muscle loss and GLP-1R agonists use. 2026.
- 2.The Effects of GLP-1 Agonists on Musculoskeletal Health and Body Composition. 2026.
- 3.Weight Reduction with GLP-1 Agonists and Paths for Preserving Muscle. 2025.
- 4.Nilsson MI, Xhuti D, de Maat NM, et al. Obesity and Metabolic Disease Impair the Anabolic Response to Protein Supplementation and Resistance Exercise: A Retrospective Analysis of a Randomized Clinical Trial with Implications for Aging, Sarcopenic Obesity, and Weight Management. Nutrients. 2024.
- 5.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
- 6.Tuttle KR, Lakshmanan MC, Rayner B, et al. Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7). Diabetes, Obesity & Metabolism. 2019.
- 7.Flack KD, Hays HM, Moreland J, et al. Exercise for Weight Loss: Further Evaluating Energy Compensation with Exercise. Medicine & Science in Sports & Exercise. 2020.
- 8.Rooks D, Yates DP, Neelakantham S, et al. Cardiac safety of chronic inhibition of the myostatin-activin pathway with bimagrumab in healthy older adults. The Journal of Clinical Endocrinology & Metabolism. 2026.
- 9.Jensen SBK, Fiorenza M, Juhl CR, et al. Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity. Sports Medicine. 2026.
- 10.Malin SK, Francois ME, Eichner NZM, et al. Impact of short-term exercise training intensity on β-cell function in older obese adults with prediabetes. Journal of Applied Physiology. 2018.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.


